Reports Full-Year Diluted EPS of $2.39 on a GAAP Basis, a Decrease of 12.1 Percent; Adjusted Diluted EPS of $10.12, a Decrease of 8.9 Percent; These Results Include an Unfavorable Impact of $1.52…
#stockmarket #breaking
AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results – AbbVie
